| Price | 525.00p on 26-06-2026 at 18:35:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 550.00p |
| Sell | 500.00p |
| Last Trade: | Buy 1.00 at 550.00p |
| Day's Volume: | 13 |
| Last Close: | 525.00p |
| Open: | 525.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 525.00p - 525.00p |
| 52wk Range: | 425.00p - 1,020.00p |
| Market Capitalisation: | £81.30m |
| VWAP: | 547.67308p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1 | 550.00p | SI Trade |
10:37:46 - 26-Jun-26 |
| Buy* | 3 | 550.00p | SI Trade |
10:37:46 - 26-Jun-26 |
| Buy* | 7 | 550.00p | Ordinary |
10:34:12 - 26-Jun-26 |
| Unknown* | 0 | 550.00p | SI Trade |
10:26:19 - 26-Jun-26 |
| Unknown* | 0 | 500.00p | SI Trade |
10:26:19 - 26-Jun-26 |
| Buy* | 1 | 550.00p | SI Trade |
10:26:19 - 26-Jun-26 |
| Sell* | 1 | 519.75p | Ordinary |
08:33:02 - 26-Jun-26 |
| Sell* | 440 | 517.50p | Ordinary |
16:02:08 - 25-Jun-26 |
| Sell* | 107 | 500.00p | Ordinary |
15:25:48 - 25-Jun-26 |
| Sell* | 1 | 519.75p | Ordinary |
12:48:40 - 25-Jun-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Jun 2026 7:00 am | PRN | Notice of Investor Presentation |
| 15th Jun 2026 7:00 am | PRN | 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board |
| 5th Jun 2026 7:00 am | PRN | Notice of Annual General Meeting |
| 22nd May 2026 9:10 am | PRN | Director Dealing |
| 20th May 2026 7:02 am | PRN | Final Results and Notice of AGM |
| 20th May 2026 7:00 am | PRN | 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial |
| 14th May 2026 7:00 am | PRN | Appointment of Chief Financial Officer and Board Changes |
| 11th May 2026 7:00 am | PRN | 4basebio Launches Enzymatic ssDNA Platform |
| 31st Mar 2026 7:00 am | PRN | Lease of Manufacturing Facility |
| 12th Mar 2026 7:00 am | PRN | Appointment of COO |